FDA Relents, Approves Novel Antidepressant After Many Rejections

[MEDPAGE TODAY]( Daily Headlines Thursday, September 28, 2023 Today's Top Stories for {NAME} [PSYCHIATRY]( [FDA Relents, Approves Novel Antidepressant After Many Rejections]( [PUBLIC HEALTH & POLICY]( [OSHA Comes in for Both Praise and Harsh Criticism at House Hearing]( [ONCOLOGY/HEMATOLOGY]( [New Insight Into Hyperglycemia Risk With PI3K Inhibitor for Breast Cancer]( THE BREAK ROOM [Wordectomy: Guess Today’s Medical Condition]( CME SPOTLIGHT [COVID-19 Prevention for Immunocompromised Individuals]( [POP MEDICINE]( [Oktoberfest Doctor: Not the Wurst Job You Could Have]( [SPECIAL REPORTS]( [Blue Shield of California Has Fix for MA Enrollees Worried About Co-Pays]( THE BREAK ROOM [Play Today’s Wordosis]( ADVERTISEMENT [SPECIAL REPORTS]( [First Dual MD/AI Degree; Mayo's Chief AI Officer; ChatGPT Citations Pass 1K]( CME SPOTLIGHT [Patient Perspectives in Myelofibrosis Care]( [OPHTHALMOLOGY]( [Point-of-Care Eye Test Detects Aspergillus-Caused Keratitis]( [POP MEDICINE]( [220 Glasses of Water Per Day; The ERAS Era; Lip-Syncing for Healthcare CEOs]( [ONCOLOGY/HEMATOLOGY]( [Anti-TIGIT Plus Immunotherapy 'Promising' in NSCLC, Esophageal Cancer]( CME SPOTLIGHT [Uncovering the Underlying Cause of Anemia: Making a Myelodysplastic Syndrome Diagnosis]( [ONCOLOGY/HEMATOLOGY]( [Cancer Drug Shortages for Kids; Pharma Agrees to Price Talks; Catch-Up on Screening]( [ENDOCRINOLOGY]( [FDA Adds Intestinal Blockage Reports to Ozempic Labeling]( [INFECTIOUS DISEASE]( [COVID Heart Injuries Traced Back to Infected Arterial Plaque, Inflammation]( CME SPOTLIGHT [Examining B7-H3: An Emerging Therapeutic Target for Solid Tumors]( [WASHINGTON WATCH]( [Obamacare Makes Surprise Cameo in Second GOP Debate]( [SPECIAL REPORTS]( [Doc Accuses Neighbor of Hosing Him Down; LGBTQ-Serving Doc Accused of Sexual Assault]( [OPINION]( [Free Rapid COVID Tests Are Coming Back. How Should We Use Them?]( CME SPOTLIGHT [CAR T-Cell Therapy 101]( [IDSA READING ROOM]( [Rebecca Osborn, MD, on Infectious Complications of Lung Transplant for COVID-19]( [OPINION]( [The Private Sector Can Help Fill the Void in LGBTQ+ Healthcare]( [ASCO READING ROOM]( [New Tool IDs Immunotherapy-Responsive Bladder Cancer]( CME SPOTLIGHT [Advancing the Integration of CAR T-Cell Therapy in Community Oncology Centers: A Transformative Quality Improvement Initiative at a Large Community-Based Network]( [NEUROLOGY]( [FDA Panel Overwhelmingly Rejects ALS Cell Therapy]( [WASHINGTON-WATCH]( [With Shutdown Likely, Policy Experts Weigh Health Risks]( # Weekly Survey [Preferred Drug for High-Risk COVID?]( A [study]( suggested that nirmatrelvir-ritonavir (Paxlovid) and molnupiravir (Lagevrio) both reduced the risk for COVID hospitalization or death during the Omicron era[VOTE >]( Meeting Coverage Can't get away? MedPage Today brings you extensive coverage of more than 80 meetings in a wide range of specialties. [SEE ALL STORIES >]( Got a news tip? MedPage Today offers several ways to provide information to our journalists securely and confidentially. [LEARN MORE >]( [EVERYDAY HEALTH]( © 2023 MedPage Today, LLC. MedPage Today is among the federally registered trademarks of MedPage Today, LLC, and may not be used by third parties without explicit permission. You have received this email because you have registered to receive emails at www.medpagetoday.com, with the email address: {EMAIL} [Manage Email Preferences]( | [Unsubscribe](lst=NL_Daily_DHE?xid=nl_mpt_DHE_2023-09-28&eun=g1020308d0r) | [Terms of Use]( | [Privacy Policy]( Technical Questions: feedback@medpagetoday.com 114 5th Avenue, 15th Floor New York, NY 10011